On October 29, Teradyne fell 5.23% in Regular Trading, trading at $294.26 per share, with turnover of $108 million.
The move coincided with Baird lowering its price target on Teradyne to $385 from $420, while the market continued to digest the company’s latest results and forward outlook.
Teradyne reported third-quarter adjusted EPS of $2.29 on revenue of $1.306 billion, both above consensus expectations of about $2.04-$2.09 and $1.264 billion. Even so, recent market coverage indicated investor attention had shifted toward fourth-quarter guidance and the pace of AI test order conversion. Separately, ARK Investment Management disclosed a purchase of 74,691 Teradyne shares valued at about $24.18 million, but that support did not offset cautious sentiment following the target cut.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments